COVID-19 Resources (Updated 4/1/20)
Friday, March 20, 2020
The Massachusetts Academy of Dermatology is continuously monitoring the situation surrounding the coronavirus (COVID-19).
As we monitor guidelines from the Centers for Disease Control & Prevention (CDC) and the Massachusetts Department of Public Health, we invite you to do the same.
The following resources are designed to streamline the flood of COVID-19 Coronavirus information circulating and offer tips to help you and your practice move forward in this challenging environment. Click on the links in blue below to access the full information.
Teledermatology Toolkit | American Academy of Dermatology
With COVID-19 spreading widely in the U.S., you may wish to use telemedicine to treat your Medicare patients without putting their health, or your own, at risk. Telemedicine may be of particular use for patients at higher risk of infection (the elderly and those with other health issues) and for non-urgent appointments.
Coding a Telehealth Visit | American Academy of Dermatology
Teledermatology services can be performed in one of two ways: Store and forward (asynchronous): Patient submits an image or pre-recorded video for the physician to review and provide advice, e.g., a patient sends a digital image of a lesion to the physician. Live interactive (synchronous): Real-time two-way interaction between the physician and patient e.g., patient initiates a video chat with the physician to discuss a rash.
UPDATED 4/1/20 - Medicare has clarified its prior guidance regarding the proper way to bill for telehealth services during the COVID-19 pandemic. Previous guidance indicated that place of service (POS) code 02 should be used for telehealth visits with patients; the new guidance instead says to bill these visits with POS code 11 and modifier 95. Medicare says this change is intended to pay for visits that would have taken place in-person if not for the pandemic at the same rate as if they had been furnished in person.
Quick Guide to Telemedicine in Practice | American Medical Association
In an effort to keep our health care workers and patients safe amid the COVID-19 pandemic, the American Medical Association (AMA) has designed this quick guide to support physicians and practices in expediting the implementation of telemedicine, so care can continue to be provided to those who need it most.
Telemedicine Health Care Provider Fact Sheet | Centers for Medicare & Medicaid Services
Under President Trump’s leadership, the Centers for Medicare & Medicaid Services (CMS) has broadened access to Medicare telehealth services so that beneficiaries can receive a wider range of services from their doctors without having to travel to a healthcare facility. These policy changes build on the regulatory flexibilities granted under the President’s emergency declaration.
Telemedicine Vendor Options | Massachusetts Medical Society
The attached list reveals the key functionality of the various telemedicine products as reported by the vendors on their own websites.
March 16, 2020 Governor's Telehealth Order | Commonwealth of Massachusetts
To protect the Public's health and to mitigate exposure to and the spread of COVID-19, the GIC, all Commercial Health Insurers, Blue Cross and Blue Shield of Massachusetts, In.c, and Health Maintenance Organizations regulated by the Division of Insurance, are hereby required to allow all in-network providers to deliver clinically appropriate, medically necessary covered services to members via telehealth.
Managing Your Practice through the COVID-19 Outbreak | American Academy of Dermatology
The AAD has developed downloadable recommendations for dermatology practices based on CDC and WHO guidance. These recommendations focus on screening patients prior to arrival, disinfecting practice surfaces, and using the proper products for sanitization.
COVID-19 Resources for Physicians | Massachusetts Medical Society
Clinicians are encouraged to familiarize themselves with the latest guidance from the Centers for Disease Control and Prevention (CDC) and the Massachusetts Departments of Public Health (MA DPH) below concerning current epidemiology, prevention recommendations, and clinical management for patients with COVID-19 infection.
Use of Biologics During COVID-19 | American Academy of Dermatology
...the Academy strongly recommends that patients should not stop biologic therapy without consulting their physicians. To better serve patients and their physicians, the Academy is putting forth the following interim recommendations.
If you have any questions, concerns, or other information you'd like to share with our members, please email our office. We will continue to update this list of resources on our website.